Neurotropin (NTP) is a Japanese analgesic agent for treating neuropathic pain; however, its method of action remains unclear. This study examined the effects of NTP on the activity of small dorsal root ganglion (DRG) neurons using whole-cell patch clamp recordings. After 3 days of treatment, NTP decreased current injection-induced firing activity of cultured DRG neurons by raising the current threshold for action potential generation. Additionally, NTP increased the sustained component of voltage-gated potassium (K v ) channel currents without affecting other K þ currents. These results suggest that NTP inhibits the firing activity of DRG neurons through augmentation of sustained K v current.
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© 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/). Neurotropin (NTP), a non-protein extract from inflamed rabbit skin inoculated with vaccinia virus, is widely used in Japan as an analgesic drug for neuropathic pain. 1 One of the main consequences of NTP treatment is activation of the descending pain inhibitory system. 1 In addition, NTP exerts an anti-nociceptive effect in a central neuropathic pain model induced by noradrenergic lesions, 2 suggesting that neuronal pathways other than the descending pain inhibitory systems are involved in NTP-induced anti-nociception. The effects of NTP on the peripheral nervous system have not been fully elucidated.
Most analgesic agents currently used to treat neuropathic pain (e.g. opioids) act on the central nervous system. It is widely recognized that hyperactivity of dorsal root ganglion (DRG) neurons causes neuropathic pain. 3 Nerve injury and inflammatory stimuli cause dysfunction of K þ channels in DRG neurons, resulting in their hyperactivity. 3 Abnormal modulation of K þ channels is one of the pathophysiological mechanisms underlying neuropathic pain, highlighting the therapeutic potential of K þ channel activation.
To test that NTP affects the activity of DRG neurons, we examined its effects on cultured DRG neurons using electrophysiological recordings.
All experimental procedures were performed in accordance with the ethical guidelines of the Kyoto University Animal Research Committee. Male Wistar/ST rats (6e9 weeks; Nihon SLC, Shizuoka) were housed under constant ambient temperature (22 ± 2 C) and a lightedark cycle. NTP was obtained from Nippon Zoki Pharmaceutical (Osaka).
Primary cultures of DRG neurons were prepared as previously described with several modifications. 4 Briefly, rats were euthanized with CO 2 and the thoracic and lumbar DRGs were dissected out. Dissociated DRG neurons were cultured on Poly-L-lysine (PLL)/ laminin-coated coverslips in Neuro Medium (Miltenyi Biotec, Bergisch Gladbach, Germany) supplemented with 2% NeuroBrew-21 (Miltenyi Biotec), 0.5% GlutaMAX supplement (Invitrogen, Carlsbad, CA, USA), 100 U/mL penicillin (Nacalai Tesque, Kyoto), 100 g/mL streptomycin (Nacalai Tesque), and 0.05 g/mL 2.5S nerve growth factor (NGF; SigmaeAldrich, Saint Louis, MO, USA). On the next day, the culture medium was replaced by NTP-containing medium. After 3 days of treatment with NTP, whole-cell recordings were performed of small DRG neurons (membrane capacitance < 35 pF) 5 using an EPC-10 amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany) and Patchmaster software (HEKA). Data were filtered at 2.9 kHz and access resistances were compensated by 70%.
Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA). Differences between groups were analyzed by one-way analysis of variance (ANOVA) or twoway ANOVA followed by the Bonferroni post hoc test. Differences of P < 0.05 were considered statistically significant.
To examine the effects of NTP treatment on the firing activity of DRG neurons, current injection-evoked action potentials were recorded. Recording conditions were as follows: bath solution (composition in mM; 124 NaCl, 3 KCl, 1.2 MgCl 2 , 2.4 CaCl 2 , 10 HEPES, 26 NaHCO 3 , 1 NaH 2 PO 4 , and 10 D-glucose, pH 7.3 adjusted with NaOH) and pipette solution (composition in mM; 140 K-gluconate, 5 KCl, 2 MgCl 2 , 10 HEPES, 0.2 EGTA, and 2 ATP-Na 2 , pH 7.2 adjusted with KOH). Under control conditions (Ctrl), DRG neurons showed multiple spikes, while neurons treated with NTP (0.1 and 1 neurotropin unit (NU)/mL) exhibited a significant decrease in the number of action potentials ( Fig. 1A and B ). The current threshold for action potential generation was significantly higher in the 0.1 and 1 NU/mL NTP-treated groups than in the control group (Fig. 1C and D), suggesting that NTP dose-dependently inhibits DRG neuron action potential generation. Representative traces of inward current elicited by hyperpolarization pulses (À120 to À70 mV in 10 mV increments; 500 ms duration). Between each pulse, the membrane potential was held at À60 mV. (B) Currentevoltage relationships for K þ currents recorded from control (Ctrl) and 0.1 NU/mL NTP-treated DRG neurons. n ¼ 6e8. Ctrl vs. 0.1 NU/mL; F 1, 12 ¼ 0.00, P ¼ 0.9457; two-way ANOVA. Data are expressed as means ± S.E.M. Total RNA was isolated from DRG neurons, and first strand cDNA was synthesized by reverse transcription (RT) with random primers. The RT products were amplified with each of the primer pairs for K v genes during 30 cycles. The products were electrophoresed and stained with ethidium bromide in 2% agarose gel. Molecular weight markers were indicated on the left-hand side of the figure. The oligonucleotide sequences used for the primers were as follows: 5 0 -TTTACGAGTTGGGCGAGGAG-3 0 and 5 0 -AGTGGCGGGAGAGTTTGAAG-3 0 for K v 1.1 (570 bp); 5 0 -GTCTATCACCCAGGAACATGGAG-3 0 and 5 0 -GCTCCTGTAGGAAAGACCCAG -3 0 for K v 1.2 (423 bp); 5 0 -ACGAGTACTTCTTCGACCGC-3 0 and 5 0 -CGAACTCGTCTAGGCTCTGC-3 0 for K v 2.1 (420 bp); 5 0 -GAACCGGAGTGAGGGATGTA-3 0 and 5 0 -CATGTGGAGCTTTCCCGTCC-3 0 for K v 2.2 (648 bp).
It is widely accepted that K þ channels in DRG neurons play an important role in abnormal pain processing and its relief. 3 To determine the mechanisms regulating the inhibitory effect of NTP on DRG neuronal activity, we focused on K þ currents. The K þ current was isolated using a modified bath solution (composition in mM; 150 choline-Cl, 5 KCl, 1 MgCl 2 , 2 CaCl 2 , 1 CoCl 2 , 10 HEPES, and 10 D-glucose, pH 7.3 adjusted with KOH), which blocks Na þ and Ca 2þ currents. The voltage-independent K þ current did not significantly differ between the control and NTP-treated groups (Fig. 2) . We next examined whether NTP treatment affects voltagedependent K þ (K v ) channels. K v currents are divided into sustained and transient K v currents by the kinetics. 6 To evaluate these components separately, transient K v currents were obtained by subtracting the sustained K v currents from the total K v currents (Fig. 3A) . The total and sustained K v currents were elicited by the voltage steps from À80 and À30 mV, respectively. Sustained K v currents were significantly larger in NTP-treated DRG neurons than in control neurons (Fig. 3B, D) , whereas NTP did not affect transient K v currents (Fig. 3C, E) . By contrast, acute application of NTP did not affect sustained K v currents (Fig. 3F) . The mRNA levels of K v channel subunits were not changed in NTP (3-day)-treated DRG neurons (data not shown), while sustained K v channel subunits were expressed in non-treated cultured DRG neurons (Fig. 3G) . These results indicate that 3-day treatment with NTP selectively potentiates a sustained K v current in DRG neurons.
In the present study, we showed that NTP decreased the firing activity of DRG neurons by raising the current threshold for firing. Additionally, NTP selectively increased sustained K v currents. Due to their slow deactivation, sustained K v currents are involved in relatively long-term inhibition following action potentials (e.g. generation of large after-hyperpolarization), resulting in a prolonged refractory period. 7 Considering the inhibitory mechanisms of sustained K v channels, NTP might inhibit strong stimulationinduced repetitive firing in DRG neurons. In support of this hypothesis, a previous study reported that NTP decreases capsaicininduced neuropeptide release without affecting basal release. 8 While the effects of NTP on the descending pain inhibitory system are well-accepted, 1 our results indicate that NTP also affects the peripheral nervous system.
In this study, we showed that 3-day, but not acute, treatment with NTP increased sustained K v current without affecting mRNA expression levels. These observations suggest that NTP potentiates K v channels by post-translational modification. For example, NGF treatment increases membrane expression of K v 2.1 without changing its mRNA expression. 9 Phosphorylation is one of the main post-translational modification of K v channels, 10 and phosphorylation of serine residues in delayed rectifier K þ channels, such as K v 2.1, positively regulates their surface expression. 11 Recent research demonstrated that NTP promotes NGF signaling and the downstream activation of several protein kinases, 12 suggesting that enhanced NGF signaling is involved in the NTP-induced increase in sustained K v current. Considering that NTP directly elicits inward current in noradrenergic neurons in the central nervous system, 13 it might modulate the descending pain inhibitory system and peripheral sensory system via distinct mechanisms. Further studies are needed to clarify the precise cellular mechanisms underlying these dual effects of NTP.
In conclusion, the present study demonstrated that NTP inhibits the activity of cultured DRG neurons through potentiation of sustained K v currents. These findings support the hypothesis that NTP acts on both the central and peripheral nervous systems, highlighting the unique anti-nociceptive mechanisms of NTP.
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